©2024 Stanford Medicine
Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension
Not Recruiting
Trial ID: NCT04060641
Purpose
The purpose of this study is to assess the effectiveness of a multi-gene panel to determine
which subjects are likely to respond to renal denervation therapy with Medtronic's Symplicity
Spyral™ multi-electrode renal denervation system.
Official Title
Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension
Stanford Investigator(s)
David Lee, MD
Professor of Medicine (Cardiovascular Medicine)
Eligibility
Inclusion Criteria:
1. Individual is currently or has previously been enrolled in a Medtronic clinical study
utilizing the Symplicity Spyral™ multi-electrode renal denervation system.
2. Subject received Renal Denervation.
3. Subject has met the primary efficacy endpoint for the Medtronic Symplicity Spyral
study and which arm they were randomized to.
4. Individual agrees to have all study procedures performed, and is competent and willing
to provide written, informed consent to participate in this clinical study.
Exclusion Criteria:
- Unable to provide written, informed, consent
Intervention(s):
genetic: Geneticure for RDN Genetic Panel
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305